Index by author

The authors explored the effect of multimodal imaging (CT perfusion and/or CT angiography) versus noncontrast CT alone on time to treatment and outcomes in the IMS III trial. Of 656 subjects enrolled in the trial, 90 (13.7%) received CTP and CTA, 216 (32.9%) received CTA (without CTP), and 342 (52.1%) received NCCT alone. Median times from stroke onset to IV tPA in the CTP+CTA, CTA, and NCCT groups were 120.5 vs 117.5 vs 120 minutes, respectively. They conclude that the use of CTA (with or without CTP) did not delay IV tPA or endovascular therapy compared with NCCT in the IMS III trial.

The authors performed a retrospective blinded analysis of cervical cord MR imaging examinations of 50 patients with MS. In each patient, 2 neuroradiologists measured the number of focal lesions and overall lesion conspicuity in the STIR/proton density–weighted TSE and WM-suppressed T1 inversion recovery sequence groups. Substantial interreader agreement was noted on the WM-suppressed T1 inversion recovery sequence compared with STIR/proton density–weighted TSE. Average lesion conspicuity was better on the WM-suppressed T1 inversion recovery sequence. Additionally, spurious lesions were more common on STIR/proton density–weighted TSE than on the WM-suppressed T1 inversion recovery sequence. They conclude that the WM-suppressed T1 inversion recovery sequence could potentially be substituted for either STIR or proton density–weighted TSE sequences in routine clinical protocols.